tag:blogger.com,1999:blog-65290351498523323002024-02-06T22:25:21.664-08:00Nevada Biotechnology NewsDedicated to the Advancement of Biotechnology and Life Science in NevadaJohn Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.comBlogger139125tag:blogger.com,1999:blog-6529035149852332300.post-91820892536796436142014-05-26T09:30:00.001-07:002014-05-26T09:30:06.898-07:00NevBio to have President of Roseman University of Health Sciences, Renee Coffman, speak on the Roseman Teaching Method<div class="MsoNoSpacing">
<span style="font-size: 16pt;">Dr. Renee
Coffman, President of Roseman University of Health Sciences, will speak on T</span><span style="font-size: 16pt;">uesday, May 20,
2014 on the th</span><span style="font-size: 16pt;">e "Roseman
Method",</span></div>
<div class="MsoNoSpacing">
<span style="font-size: 16pt;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiA368y7zcZqJa4pxB-jc77claQNmZcYO-nfVnv2vWfTkj5wwQl-5NLAKxDRXFFPLILnuswgs9g3Pa8a8tHzqGOwVTQp7LsGMEs4Z6_FDudVoGMQK_Hq4beNIQTKlC5-EcTegPZQR6mtj4/s1600/Roseman_Horizontal.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiA368y7zcZqJa4pxB-jc77claQNmZcYO-nfVnv2vWfTkj5wwQl-5NLAKxDRXFFPLILnuswgs9g3Pa8a8tHzqGOwVTQp7LsGMEs4Z6_FDudVoGMQK_Hq4beNIQTKlC5-EcTegPZQR6mtj4/s1600/Roseman_Horizontal.jpg" height="93" width="320" /></a></div>
<div class="MsoNoSpacing">
<span style="font-size: 16pt;">The Roseman Method is an innovative teaching method:</span></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">1. <b>Block Curriculum</b>. Each
class is an immersion into the topic with one course at a time, six hours a day
for five days a week, which allows students to completely focus on that topic
to gain a deeper understanding.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">2. <b>Content Mastery</b>.
Roseman does not have grades. Students either pass or fail. To pass the
students must achieve 90% on all tests. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">3. <b>Variety of Teaching
Methods</b>. Roseman understands that students learn the material in different ways
which is why they employ several methods of teaching - lecture, hands-on,
experimental and real-life situations.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">4. <b>Collaboration</b>. Students
must work together as part of the learning process. Because students are not
graded, there is no competition between students. Students feel free to help
other. It's a positive environment.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">"When You Build a
University from Scratch, You are Free to Invent and Improve on the Status
Quo."<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">The results are
impressive. Roseman students in Pharmacy, Nursing and Dental Medicine consistently pass 95% on their first time on their examination boards. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiPDAwZp_9aisUqjn_TNUtC5IIm1A3d2Zclhl0EGxGK-7yycxZDmU6BOXDRai7wVXHlmUV6LeDrjx4iOsrWqwQOE63m1UD4B0O9UxCPZL9Z9R1N2SLkP7b4BKXek9QayCqeYnAdneBT0yY/s1600/Dr.+Renee+Coffman.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiPDAwZp_9aisUqjn_TNUtC5IIm1A3d2Zclhl0EGxGK-7yycxZDmU6BOXDRai7wVXHlmUV6LeDrjx4iOsrWqwQOE63m1UD4B0O9UxCPZL9Z9R1N2SLkP7b4BKXek9QayCqeYnAdneBT0yY/s1600/Dr.+Renee+Coffman.jpg" /></a></div>
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">Dr. Renee Coffman is the
president and co-founder of Roseman University which offers Colleges of
Pharmacy, Nursing and Dental Medicine, an MBA program and has more than 1,000
students. She holds a pharmacy degree from Ohio Northern University and her
doctorate is in industrial and physical pharmacy from Purdue University.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-size: 16.0pt;">Dr. Coffman's mentor is
co-founder, Dr. Harry Rosenberg. He taught her that whether it's a student in a
classroom or an employee, no one walks in hoping to fail. "Your main focus
is really simple-it's to help that individual succeed. I strive every day to
ensure that my students can succeed in the classroom and that people who work
for Roseman have opportunity to succeed in their jobs," she told the <i>Las
Vegas Woman Magazine</i>, May 2013.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1tag:blogger.com,1999:blog-6529035149852332300.post-54906535117554064542014-05-04T22:30:00.001-07:002014-05-04T22:30:55.154-07:00City of Las Vegas to Talk About $1 Million Grant for Contest for Best Idea for Las Vegas on April 30, 2014<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgnk35-5KR4TuGvGqY56WeG3GOdImaYIhx346wOurHsOOPVlXpgWuAmqljlD7JLKTWVeu4CZ8jlIy9mjecyREJxJ6ZZVFzu6u_M6_Esx-tDfoSowQoZ1uVaPvWxRtMt2HiCBn8H6r7O_lY/s1600/City+of+Las+Vegas+Seal.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgnk35-5KR4TuGvGqY56WeG3GOdImaYIhx346wOurHsOOPVlXpgWuAmqljlD7JLKTWVeu4CZ8jlIy9mjecyREJxJ6ZZVFzu6u_M6_Esx-tDfoSowQoZ1uVaPvWxRtMt2HiCBn8H6r7O_lY/s1600/City+of+Las+Vegas+Seal.jpg" height="200" width="200" /></a></div>
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">The City of Las Vegas launches Strong Cities, Strong Communities Challenge: $900,000 of cash prizes available for effective solutions to help grow the local economy.</span><br />
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;"><br /></span>
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">The Strong Cities, Strong Communities (SC2) Challenge is a prestigious international competition that will award $900,000 in prizes for the most innovative, creative & transformational economic development plans to help revitalize targeted areas within the city. </span><br />
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;"><br /></span>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXLBryKEoXfCG4ECesSE0h9ZPU9x8hGsEUImxR7otPE25ADYAKHXr-Ms_sXec01ZJttCAy1kAYFH1E6Fu5AVUSTqE9A7Ub2VhmXlVD4w5D0aP1X8WTWrT-_H-fh25-hlM0sXmUnuqLwng/s1600/SC2.JPG" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXLBryKEoXfCG4ECesSE0h9ZPU9x8hGsEUImxR7otPE25ADYAKHXr-Ms_sXec01ZJttCAy1kAYFH1E6Fu5AVUSTqE9A7Ub2VhmXlVD4w5D0aP1X8WTWrT-_H-fh25-hlM0sXmUnuqLwng/s1600/SC2.JPG" /></a></div>
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">The SC2 Challenge is federally funded by a $1 million grant from the U.S. Department of Commerce's Economic Development Administration (EDA). It was awarded in 2012 to three U.S. cities: Las Vegas, Nevada; Greensboro, North Carolina; and Hartford, Connecticut.</span><br />
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;"><br /></span>
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">The goal of the competition is to assist participating cities, including Las Vegas, in cultivating well-conceived, innovative ideas to revitalize four targeted areas within the community: Cashman Center, the Las Vegas Medical District, business parks, and existing Redevelopment projects.</span><br />
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;"><br /></span>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgikOhvJdBvD5dY9XHQz3hARQgLCVqyXFzesLUveMqhYo_vOOIwE3rjrU5v_O32-EEQa1VJXBDM4oHR_Wt4ciP7TMay62mI7ZSRk8xBVEXpvYhKrz7bPjfbDfsZrfeYfqmXHLPSqdVTF2E/s1600/Bill+Arent.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgikOhvJdBvD5dY9XHQz3hARQgLCVqyXFzesLUveMqhYo_vOOIwE3rjrU5v_O32-EEQa1VJXBDM4oHR_Wt4ciP7TMay62mI7ZSRk8xBVEXpvYhKrz7bPjfbDfsZrfeYfqmXHLPSqdVTF2E/s1600/Bill+Arent.jpg" height="149" width="200" /></a></div>
<span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">Bill Arent is the Director of Economic & Urban Development Department for the the City of Las Vegas. </span><span id="yui_3_13_0_1_1399231602082_334035" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">The Office creates, coordinates and encourages new development and redevelopment in Las Vegas, with an emphasis on the downtown area. It strives to increase and diversify the city's economic base through business attraction, retention and expansion programs. </span><span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">He was promoted to this position in October 2009. </span><span id="yui_3_13_0_1_1399231602082_334018" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 16pt;">Employed with the city since 1997, Arent has held numerous positions in housing development, economic development and redevelopment. He was the senior project manager for Symphony Park, and has negotiated development agreements for the Cleveland Clinic Lou Ruvo Center for Brain Health and The Smith Center for the Performing Arts.</span><span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;"> </span><br />
<div id="yui_3_13_0_1_1399231602082_334037" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px;">
Arent holds a Bachelor of Arts in Economics from the University of Pennsylvania and a Master of Public Administration from the University of Nevada, Las Vegas. He is certified as an economic development finance professional.</div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-66375890393743097492014-05-04T22:19:00.002-07:002014-05-04T22:19:19.133-07:00Medical Marijuana: Talk by Tick Segerblom & Bio-Chemistry by UNLV Scientist, Martin Schiller on March 26, 2014<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2wn7ON8uY5X0uJ8_yTjsXQ-lVsvVIcun8U802WLFErbmepMrdYJEhDWF5DRPVoXlIALAwNL4DoBtZGcYN-lOfSSousdj-fVj2mSLSFwJPv5oijOf804mj_7UrhiVqOeNLaO2n9-ALzu4/s1600/Tick+Segerblom.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2wn7ON8uY5X0uJ8_yTjsXQ-lVsvVIcun8U802WLFErbmepMrdYJEhDWF5DRPVoXlIALAwNL4DoBtZGcYN-lOfSSousdj-fVj2mSLSFwJPv5oijOf804mj_7UrhiVqOeNLaO2n9-ALzu4/s1600/Tick+Segerblom.jpg" height="200" width="133" /></a></div>
<div align="left" id="yui_3_13_0_1_1399231602082_264885" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
Richard "Tick" Segerblom is a Nevada State Senator. He was first elected to the Nevada Assembly in 2006. He was elected to the Nevada State Senate in 2012 to represent Senate District 3. He is a fourth generation Nevada representative. His mother, Gene Segerblom (née Wines), served in the Nevada Assembly from 1992 through 2000 and was a member of the Boulder City Council. His grandmother, Hazel Wines (née Bell), served in the Nevada Assembly from 1934 - 1936 representing Humboldt County. Segerblom's great-grandfather was William "Johnny" Bell representing Humboldt County from 1906 to 1914 in the Nevada Senate. Segerblom was Chairman of the Nevada Democratic Party from 1990 to 1994.</div>
<div align="left" id="yui_3_13_0_1_1399231602082_264897" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
Segerblom represents Senate District 3 which encompasses a portion of urban Clark County including portions of the City of Las Vegas. </div>
<div align="left" id="yui_3_13_0_1_1399231602082_264895" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
Tick is also a practicing attorney.</div>
<div align="left" id="yui_3_13_0_1_1399231602082_264895" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div id="yui_3_13_0_1_1399231602082_264948" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<span id="yui_3_13_0_1_1399231602082_264947" style="font-weight: 700;">Nevada Set to Make Millions on Medical Marijuana</span></div>
<div id="yui_3_13_0_1_1399231602082_264933" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<span id="yui_3_13_0_1_1399231602082_264952">According to an article in the <em>Las Vegas Review-Journal</em> last July, Tick Segerblom told a group that </span><span id="yui_3_13_0_1_1399231602082_264942" style="font-size: 16pt;">pot dispensary owners in Nevada are in a perfect position to make millions of dollars because the state is the only one in the country that plans to accept out-of-state medical marijuana cards.</span></div>
<div id="yui_3_13_0_1_1399231602082_264938" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<span id="yui_3_13_0_1_1399231602082_264937">State Senator Tick Segerblom helped pass the law (3) that helped legalize the dispensaries. As reported, Tick believes that the medical marijuana business to be a boon not only for state coffers but also for the 40 operators who will be able to sell medical pot to anybody who holds a card from another state.</span></div>
<div id="yui_3_13_0_1_1399231602082_264940" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div id="yui_3_13_0_1_1399231602082_264955" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<span id="yui_3_13_0_1_1399231602082_264954">At last tally 19 states had legalized medical marijuana - from Colorado to Oregon and Washington to Connecticut, Vermont and Delaware.</span></div>
<div style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div id="yui_3_13_0_1_1399231602082_264958" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<span id="yui_3_13_0_1_1399231602082_264957">Tick went on to say that "...with the millions of people who visit here, I don't need to tell you how profitable it can be. And Nevada needs the money. It's very short on revenue. But we're not going to become a Venice Beach. Nevada has a thorough and fair bill, and we're going to regulate this industry the right way." </span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1tag:blogger.com,1999:blog-6529035149852332300.post-81840113658947314812014-05-04T22:11:00.003-07:002014-05-04T22:11:45.596-07:00NevBio to host Zach Miles, Esq., the New Director of Tech Transfer at UNLV on February 26, 2014<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh0UKtRwGRJKiX16Ptp4-iHQcGvgYR8UYhl88bU3gCrNDmJKIpOwa6TVfOzkdjliC7aQqQMi9HfrpwGSagRCTzEOB3fB9jJZuBTVXtqtvIv9HTLYURJXM9qo-MMxD3nQKkcrVeMwWq5-0o/s1600/Zach+Miles.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh0UKtRwGRJKiX16Ptp4-iHQcGvgYR8UYhl88bU3gCrNDmJKIpOwa6TVfOzkdjliC7aQqQMi9HfrpwGSagRCTzEOB3fB9jJZuBTVXtqtvIv9HTLYURJXM9qo-MMxD3nQKkcrVeMwWq5-0o/s1600/Zach+Miles.jpg" /></a></div>
<div align="left" id="yui_3_13_0_1_1399231602082_241649" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
Zach Miles, Esq. was hired in November 2013 as the Executive Director of UNLV Technology Transfer and Development. His job is to manage the commercialization of intellectual property owned by UNLV. Prior to UNLV, Miles worked with the Tech Venture & Commercialization at the University of Utah where he helped numerous startups. </div>
<div align="left" id="yui_3_13_0_1_1399231602082_241649" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div align="left" id="yui_3_13_0_1_1399231602082_241665" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
He was the Deputy Executive Director when University of Utah was named the top university in the country for creating startup companies (something needed in Southern Nevada) by the Association of University Technology Managers, beating out schools such as MIT, Johns Hopkins and Purdue.</div>
<div align="left" id="yui_3_13_0_1_1399231602082_241663" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div align="left" id="yui_3_13_0_1_1399231602082_241663" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
He has a BS in Microbiology from Weber State University and a JD from the University of New Hampshire School of Law.</div>
<div align="left" id="yui_3_13_0_1_1399231602082_241663" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div align="left" id="yui_3_13_0_1_1399231602082_241663" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
<div align="left" id="yui_3_13_0_1_1399231602082_241663" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; padding: 0px;">
<br /></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-33693012324735484882014-05-04T22:01:00.001-07:002014-05-04T22:01:07.180-07:00NevBio's Deans' Talk & Legislator Luncheon on January 21, 2014<div id="yui_3_13_0_1_1399231602082_238753" style="background-color: white; font-family: Arial, Helvetica, sans-serif;">
<span id="yui_3_13_0_1_1399231602082_238755"><span style="font-size: large;">NevBio is sponsoring our first "Deans' Talk" with two science deans. T</span></span><span style="font-size: large;">hey will talk about the increasing demand for science education for careers in medicine and research:</span></div>
<div id="yui_3_13_0_1_1399231602082_238751" style="background-color: white; font-family: Arial, Helvetica, sans-serif;">
<span id="yui_3_13_0_1_1399231602082_238750"><span style="font-size: large;">* How is Southern Nevada meeting this demand?</span></span></div>
<div id="yui_3_13_0_1_1399231602082_238772" style="background-color: white; font-family: Arial, Helvetica, sans-serif;">
<span id="yui_3_13_0_1_1399231602082_238788"><span style="font-size: large;">* What are the accomplishments?</span></span></div>
<div id="yui_3_13_0_1_1399231602082_238743" style="background-color: white; font-family: Arial, Helvetica, sans-serif;">
<span id="yui_3_13_0_1_1399231602082_238775"><span style="font-size: large;">* How do we prepare for Southern Nevada's medical & biomedical future?</span></span></div>
<div id="yui_3_13_0_1_1399231602082_238743" style="background-color: white; font-family: Arial, Helvetica, sans-serif;">
<span style="font-size: large;"><br /></span></div>
<div id="yui_3_13_0_1_1399231602082_238743" style="background-color: white; font-family: Arial, Helvetica, sans-serif;">
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgx_JpYE9GPrRmWrDyzNm8OEGKWfqMrXOtfVAuoTgsTbJV-CX17wS2e3uqEkfz7jW8WIFfx2MjLpotOr7HmvkEniWGc88-7X20eX5UjZgVUAieoyFRxlwnBKW30dKRsj0iKgRBHcSd2etg/s1600/Tim+Porter.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgx_JpYE9GPrRmWrDyzNm8OEGKWfqMrXOtfVAuoTgsTbJV-CX17wS2e3uqEkfz7jW8WIFfx2MjLpotOr7HmvkEniWGc88-7X20eX5UjZgVUAieoyFRxlwnBKW30dKRsj0iKgRBHcSd2etg/s1600/Tim+Porter.jpg" /></a></div>
<div align="left" id="yui_3_13_0_1_1399231602082_238690" style="padding: 0px;">
<span style="font-size: large;"><span id="yui_3_13_0_1_1399231602082_238694" style="text-decoration: underline;">Timothy L. Porter, PhD</span>. was hired as the Dean of the UNLV College of Sciences. He was a professor of physics and astronomy at Northern Arizona University. He<span id="yui_3_13_0_1_1399231602082_238733"> served as the director of the university's Growing Biotechnology Initiative. He holds five U.S. patents for the development of specialized sensors. </span><span id="yui_3_13_0_1_1399231602082_238700">Prior to his time at NAU, Porter served as a research associate at Arizona State University and as a staff physicist for the Hughes Aircraft Company.</span></span></div>
<div id="yui_3_13_0_1_1399231602082_238702" style="padding: 0px;">
<span style="font-size: large;">Porter earned a Ph.D. in physics from Arizona State University in 1988. He received M.S. and B.S. degrees in physics from California State University</span><span style="font-size: 19px;">.</span></div>
<div id="yui_3_13_0_1_1399231602082_238702" style="font-size: 19px; padding: 0px;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_CmuzpN2v6IBemUZoSsufGR8B4OJeber2VUSJtT3aDq89cpfxaU1LvR9XAM_MSdtrVRdLE12lLsT2hcJUBNTI5cxUIN_9u4N280V-NJ6fLnAX1zjI0_FZbRWd7byuICJosEiPLsvQ0T8/s1600/Andy+Kuniyuki.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_CmuzpN2v6IBemUZoSsufGR8B4OJeber2VUSJtT3aDq89cpfxaU1LvR9XAM_MSdtrVRdLE12lLsT2hcJUBNTI5cxUIN_9u4N280V-NJ6fLnAX1zjI0_FZbRWd7byuICJosEiPLsvQ0T8/s1600/Andy+Kuniyuki.jpg" height="149" width="200" /></a></div>
<div id="yui_3_13_0_1_1399231602082_238702" style="padding: 0px;">
<span style="font-size: large;"><span id="yui_3_13_0_1_1399231602082_238802"><span id="yui_3_13_0_1_1399231602082_238804" style="text-decoration: underline;">Andy Kuniyuki, PhD</span>currently serves as the Dean of Liberal Arts and Sciences at Nevada State College. He received his B.S. in biology from the University of Hawaii and his Ph.D. in genetics from the University of California. Dr. Kuniyuki's belief that Biology is preeminent began with his study of the Hawaiian Drosophila and continued with his many research endeavors employing monoclonal antibody, tissue culture, oligonucleotide and immunodiagnostic technologies. </span><br /><br /><span id="yui_3_13_0_1_1399231602082_238811">Dr. Kuniyuki's passion for teaching took him deep within the cellblocks of San Quentin Prison where he taught genetics to a captured audience while completing his doctorate at Berkeley. </span></span></div>
</div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-9821924589057227282014-05-04T13:18:00.001-07:002014-05-04T21:08:09.695-07:00NevBio Welcomes Trevor Dardik, CEO & Founder of UniTsem at December 12, 2013 Luncehon<div class="separator" style="clear: both; text-align: center;">
</div>
<div id="yui_3_13_0_1_1399231602082_27163" style="background-color: white;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj7Xi5KbAKrlsmAMVLZBynblaVpXIP5zqpl8uqJEX0tt93FAWhmYJTN40J2VtwP3zoo8kQE4VFvqP1F3LqJ_gY9L5LrkIxxgAtYliYjqVA_YPQiMkck8MdrMNfpmgdcFBpL4Q1ays8Lw_4/s1600/Trevor+Dardik.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj7Xi5KbAKrlsmAMVLZBynblaVpXIP5zqpl8uqJEX0tt93FAWhmYJTN40J2VtwP3zoo8kQE4VFvqP1F3LqJ_gY9L5LrkIxxgAtYliYjqVA_YPQiMkck8MdrMNfpmgdcFBpL4Q1ays8Lw_4/s1600/Trevor+Dardik.jpg" height="200" width="199" /></a></div>
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Trevor was invited by the Downtown Project to stay at Tony Hsieh's crash pad. The crash pad is a set of condos for important visitors such as entrepreneurs, company founders & CEOs. </span><br />
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"><br />
</span><br />
<div id="yui_3_13_0_1_1399231602082_218792">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Trevor Dardik is the CEO & Co-founder of UniTsem. He was the president of LifeWaves International LLC for five years. </span><span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">LifeWaves </span><span id="yui_3_13_0_1_1399231602082_218859" style="font-family: Arial, Helvetica, sans-serif; font-size: large;"><span id="yui_3_13_0_1_1399231602082_218858">monitors 11 different bioindicators to understand how the body responds to exercise. It uses the </span>HeartWave </span><span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Cycles Exercise® Program and state-of-the-art Rhythmic Biofeedback system to improve one's health. </span></div>
<div id="yui_3_13_0_1_1399231602082_218875">
</div>
<div id="yui_3_13_0_1_1399231602082_218865">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Trevor has a BAIS in Biology from Fairleigh Dickinson University in Hackensack, NJ and was a former professional track athlete.</span><br />
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"><br /></span>
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Trevor will talk about the wearable EKG monitor that his company is delivering along with other medical devices products his Italian company is selling in Europe.</span></div>
</div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-22684525396890350012014-05-04T13:10:00.002-07:002014-05-04T13:10:42.013-07:00NevBio and CEO-CFO International Hosts Delegation from Kazakhstan on Nov 20, 21 & 22, 2013<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhMZOhc5Q538QRyiRhGzuODJ6ZVY_9qQxVak5XC29KEAQ2N8vzKsNcnitGOnHQ9QS1HOhMaXuv7iKPB2t7anvY35I-ymnIv1a24e59NEC1neOMb7K8sbcSGYjVfo3V8Kmpe7UMRh0IP3cs/s1600/Kazakhstan.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhMZOhc5Q538QRyiRhGzuODJ6ZVY_9qQxVak5XC29KEAQ2N8vzKsNcnitGOnHQ9QS1HOhMaXuv7iKPB2t7anvY35I-ymnIv1a24e59NEC1neOMb7K8sbcSGYjVfo3V8Kmpe7UMRh0IP3cs/s1600/Kazakhstan.jpg" /></a></div>
NevBio and the CEO-CFO Group International hosted of delegation of professors, governmental officials and businessmen for three days of classes at the Mansion formerly owned by Mike Tyson which is now owned by Equiinet International.<br />
<br />
During the three days, the delegation attended classes and tours of businesses. Speakers included Richard Helfrich who spoke on creating innovation in the United States and other countries. Steve Curtis spoke on Unmanned Aerial Vehicles in Nevada and its future in the world. Dr. Oliver Hemmers spoke on common challenges that Kazakhstan and Nevada face. Zane Wilson, CEO of GMIS spoke about the medical isotope industry. Leith Martin, CEO of Equiinet spoke about small business innovation and their company's product which is one box to handle voice, internet, security and backup. Matthew Waymire talked about how Americans "tinker" and develop new products - new products that came out of garages such as Apple, Hewlett Packard and others. Kent Rippy talk about marketing and social media. Former Congresswoman Shelley Berkley spoke about her relationship with Kazakhstan and how she helped the US work closer with Kazakhstan. <br />
<br />
Trips were taken to the University of Nevada of Las Vegas (UNLV) College of Sciences, UNLV Gaming Institute and UNLV College of Engineering. The delegation visited with Dr.Andy Kunuki at Nevada State College where they discussed new teaching methods. The group toured the Atomic Testing Museum. Kazakhstan also hosted USSR's nuclear testing site.John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-68196913286352567522014-04-30T08:21:00.001-07:002014-04-30T08:21:47.920-07:00NevBio to Join the SciTech Showcase & Dinner on October 24, 2013<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background: white; mso-cellspacing: 0in; mso-padding-alt: 0in 0in 0in 0in; mso-yfti-tbllook: 1184; width: 100%px;">
<tbody>
<tr>
<td style="padding: 0in 0in 0in 0in;">
<div class="MsoNormal" style="margin-bottom: 0.0001pt;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"><i>Last Day to Buy
Tickets: </i> SciTech Showcase
& Dinner on Oct 24, 2013 in Las Vegas at the World Market Center<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
<div class="MsoNormal" style="margin-bottom: 0.0001pt;">
<br /></div>
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background: white; mso-cellspacing: 0in; mso-padding-alt: 0in 0in 0in 0in; mso-yfti-tbllook: 1184; width: 100%px;">
<tbody>
<tr>
<td style="padding: 0in 0in 0in 0in;">
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"> <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">SCITECH DINNER SPEAKERS:<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<br /></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Nancy Phillips, CEO of ViaWest<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">One of the Largest Privately Owned Data-Center Companies in the
Nation <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">and<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Darik Volpa, CEO of Understand.com<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Named "Most Inspiring" by PharmaVOICE<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">on<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Thursday, October 24, 2013<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">4 pm Showcase & Cocktails<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">6 pm Dinner & Program<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">at<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">World Market Center<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">RSVP <a href="http://r20.rs6.net/tn.jsp?f=001dCMh95svbN2vGckPD745SW9RRi5IIaOB5t2I4qaXN_PCZJiwI14TH_pnfS40AsuHrHnhLiummASmaWY5eWd7HE1gxMkoy-tSj7LBSHhZiQMZkxEdtIabWd2RqBkceVxX9RvlIbwolaXZVDDWaAvomoKaIYK7whgjrbQMR_pZwdVM_LzNt9nccPFirmAc3G8D&c=VhfO06r9X-u8QIpeFBkUjw7IO7PfRDaFcu_vTU35PTuGFp1XhHuCFw==&ch=n3vpMhXpBb1lYJAQhW0ggHBqz5yCZtfIzGzf4WZHiQhbSxY1V9uioA==" target="_blank"><b><span style="color: blue; text-decoration: none; text-underline: none;">here</span></b></a><o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Last day to buy tickets (Oct 15th)<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
<div class="MsoNormal" style="margin-bottom: 0.0001pt;">
<br /></div>
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background: white; mso-cellspacing: 0in; mso-padding-alt: 0in 0in 0in 0in; mso-yfti-tbllook: 1184; width: 100%px;">
<tbody>
<tr>
<td style="padding: 0in 0in 0in 0in;">
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;"><i>Don't Miss the Exhibitors: </i><o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">NevBio, Actus Biotechnologies, BridgeBank, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">BNY Mellon, Brennan Capital Partners, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Bruce & Banka CPAs, The City of Henderson, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">City National Bank, Cleveland Clinic, CorCell, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Equon Pharmaceuticals, Inc., Hamilton Lane, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Howard & Howard, Las Vegas Business Press, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Las Vegas Internet Hospital, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Lucine Biotechnology,Inc., Maverick Angels, <o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Nevada State College, Phoenix Staff, Quantion
Advisors, Quertle, SableSystems, Skinvisible Pharmaceuticals, Ubiquita, Understand.com,<o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Varian Medical Systems & ViaWest. <o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
<div class="MsoNormal" style="margin-bottom: 0.0001pt;">
<br /></div>
<br />
<table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background: white; mso-cellspacing: 0in; mso-padding-alt: 0in 0in 0in 0in; mso-yfti-tbllook: 1184; width: 100%px;">
<tbody>
<tr>
<td style="padding: 0in 0in 0in 0in;">
<div align="center" class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: center;">
<span style="font-family: Arial, Helvetica, sans-serif; font-size: large;">Join researchers, friends, co-workers & supporters of
science and technology in Southern Nevada.<o:p></o:p></span></div>
</td>
</tr>
</tbody></table>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-90557088569394966072014-04-30T08:14:00.001-07:002014-04-30T08:15:52.001-07:00NevBio Recognizes Cancer Researchers In Southern Nevada<table bgcolor="#FFFFFF" border="0" cellpadding="15" cellspacing="0" class="yiv8458944504BlockMargin" id="yiv8458944504content_LETTER.BLOCK2" style="background-color: white; color: black; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; font-size: 13px; padding: 0px; width: 100%px; word-break: break-word;"><tbody id="yui_3_13_0_1_1398869179667_8563" style="width: 677px;">
<tr id="yui_3_13_0_1_1398869179667_8562"><td align="left" colspan="1" id="yui_3_13_0_1_1398869179667_8561" rowspan="1" style="border-spacing: 2px; color: #857458; font-family: Arial, Helvetica, sans-serif;"><div id="yui_3_13_0_1_1398869179667_8569" style="margin-bottom: 0px; margin-top: 0px;">
<div style="font-size: 10pt;">
<span id="yui_3_13_0_1_1398869179667_8568" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;"></span></div>
<div align="center" id="yui_3_13_0_1_1398869179667_8567" style="text-align: center;">
<span id="yui_3_13_0_1_1398869179667_8568" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif';"><span id="yui_3_13_0_1_1398869179667_8566" style="font-size: large;">Nevada Biotechnology & Health Science Consortium</span></span></div>
<span id="yui_3_13_0_1_1398869179667_8568" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;">
<div align="center" id="yui_3_13_0_1_1398869179667_8573" style="text-align: center;">
and Lionel Sawyer & Collins </div>
<div align="center" id="yui_3_13_0_1_1398869179667_8575" style="text-align: center;">
<span id="yui_3_13_0_1_1398869179667_8574">are pleased to host a </span>Cocktail Party </div>
<div align="center" id="yui_3_13_0_1_1398869179667_8576" style="text-align: center;">
recognizing</div>
<div align="center" style="text-align: center;">
Cancer Researchers in Southern Nevada</div>
<div align="center" style="text-align: center;">
on</div>
<div align="center" style="text-align: center;">
Saturday, September 28, 2013</div>
<div align="center" style="text-align: center;">
6 pm to 10 pm</div>
<div align="center" style="text-align: center;">
At the Loft of Mohamed Iqbal, Esq. </div>
<div align="center" style="text-align: center;">
Soho Lofts Unit 807, 900 Las Vegas Boulevard South, Las Vegas, Nevada 89101</div>
<div align="center" style="text-align: center;">
No Cost to attend, please <a href="http://r20.rs6.net/tn.jsp?e=001Vsvo5KszMSZvMCnsdNXSzIzHMSabNMrOfsu0q6zIu6YcE1MYkDYFh8AYVauBcZxJ_retkohtsEangYAdxbiKeazySIJEDLMoTRmen3ODvkbSjBrqVqqNRy5PvCawEmByoS41LZ8MUW6Wta2BlvNtUsznDjRuWQt3MOKrJEFGBMnnEjeOKy-Uwfz9eUgEsKMxmM29NLeUc9SegA60EEIzJv6PoDDSnhlU" rel="nofollow" shape="rect" style="background-color: rgba(0, 0, 0, 0); background-position: initial initial; background-repeat: initial initial; color: blue; font-weight: bold; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">RSVP</a></div>
<div align="center" style="text-align: center;">
<span style="color: red;">*</span>Limited Room<span style="color: red;">*</span></div>
</span></div>
</td></tr>
</tbody></table>
<table bgcolor="#FFFFFF" border="0" cellpadding="15" cellspacing="0" class="yiv8458944504BlockMargin" id="yiv8458944504content_LETTER.BLOCK9" style="background-color: white; color: black; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; padding: 0px; word-break: break-word;"><tbody style="width: 677px;">
<tr><td align="left" colspan="1" rowspan="1" style="border-spacing: 2px; color: #857458; font-family: Arial, Helvetica, sans-serif;"><div align="center" style="margin-bottom: 0px; margin-top: 0px; text-align: center;">
<span style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;"></span><br />
<div style="margin: 0in 0in 0pt; padding: 0px;">
<span style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;">Come join fellow researchers, friends, co-workers & supporters. Please forward this email to others that might want to attend. </span></div>
<span style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;">
</span></div>
</td></tr>
</tbody></table>
<table bgcolor="#FFFFFF" border="0" cellpadding="15" cellspacing="0" class="yiv8458944504BlockMargin" id="yiv8458944504content_LETTER.BLOCK8" style="background-color: white; color: black; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; font-size: 13px; padding: 0px; width: 100%px; word-break: break-word;"><tbody id="yui_3_13_0_1_1398869179667_8582" style="width: 677px;">
<tr id="yui_3_13_0_1_1398869179667_8581"><td align="left" colspan="1" id="yui_3_13_0_1_1398869179667_8580" rowspan="1" style="border-spacing: 2px; color: #857458; font-family: Arial, Helvetica, sans-serif;"><div id="yui_3_13_0_1_1398869179667_8579" style="margin-bottom: 0px; margin-top: 0px;">
<span id="yui_3_13_0_1_1398869179667_8578" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;"></span><br />
<div id="yui_3_13_0_1_1398869179667_8583" style="margin: 0in 0in 0pt; padding: 0px;">
<span id="yui_3_13_0_1_1398869179667_8578" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: large;">The Nevada Biotechnology & Health Science Consortium wants to recognize those who continue to research treatments for cancer in Southern Nevada and those who have supported, continue to support and/or are interested in cancer research in Southern Nevada. Please<a href="http://r20.rs6.net/tn.jsp?e=001Vsvo5KszMSZvMCnsdNXSzIzHMSabNMrOfsu0q6zIu6YcE1MYkDYFh8AYVauBcZxJ_retkohtsEangYAdxbiKeazySIJEDLMoTRmen3ODvkbSjBrqVqqNRy5PvCawEmByoS41LZ8MUW6Wta2BlvNtUsznDjRuWQt3MOKrJEFGBMnnEjeOKy-Uwfz9eUgEsKMxmM29NLeUc9SegA60EEIzJv6PoDDSnhlU" rel="nofollow" shape="rect" style="background-color: rgba(0, 0, 0, 0); background-position: initial initial; background-repeat: initial initial; color: blue; font-weight: bold; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">RSVP</a>.</span></div>
<span id="yui_3_13_0_1_1398869179667_8578" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif';"><span style="font-size: large;">
</span><div id="yui_3_13_0_1_1398869179667_8584" style="margin: 0in 0in 0pt; padding: 0px;">
<span style="font-size: large;"><br /></span></div>
<div id="yui_3_13_0_1_1398869179667_8577" style="margin: 0in 0in 0pt; padding: 0px;">
<span style="font-size: large;">We are asking researchers to provide an update on their current work in Southern Nevada by giving a brief 5 minute talk at the event (limited spots).</span></div>
</span><div style="font-size: 10pt;">
</div>
</div>
</td></tr>
</tbody></table>
<a href="https://www.blogger.com/null" name="LETTER.BLOCK9" rel="nofollow" style="background-color: white; color: #196ad4; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; font-size: 13px; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a><a href="https://www.blogger.com/null" name="LETTER.BLOCK8" rel="nofollow" style="background-color: white; color: #196ad4; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; font-size: 13px; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a><a href="https://www.blogger.com/null" name="LETTER.BLOCK11" rel="nofollow" style="background-color: white; color: #196ad4; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; font-size: 13px; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a><br />
<table bgcolor="#FFFFFF" border="0" cellpadding="15" cellspacing="0" class="yiv8458944504BlockMargin" id="yiv8458944504content_LETTER.BLOCK11" style="background-color: white; color: black; font-family: 'Helvetica Neue', 'Segoe UI', Helvetica, Arial, 'Lucida Grande', sans-serif; font-size: 13px; padding: 0px; width: 100%px; word-break: break-word;"><tbody id="yui_3_13_0_1_1398869179667_8602" style="width: 677px;">
<tr id="yui_3_13_0_1_1398869179667_8601"><td align="left" colspan="1" id="yui_3_13_0_1_1398869179667_8600" rowspan="1" style="border-spacing: 2px; color: #857458; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;"><div id="yui_3_13_0_1_1398869179667_8599" style="margin-bottom: 0px; margin-top: 0px;">
<span id="yui_3_13_0_1_1398869179667_8598" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: 16pt;"></span><br />
<div id="yui_3_13_0_1_1398869179667_8597" style="margin: 0in 0in 0pt; padding: 0px;">
<span id="yui_3_13_0_1_1398869179667_8598" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: 16pt;"><em id="yui_3_13_0_1_1398869179667_8604">We want to thank our host, Mohamed Iqbal, a litigator with Lionel Sawyer & Collins, whose practice <span id="yui_3_13_0_1_1398869179667_8627">includes international pharmacovigilance and negotiating clinical research agreements. </span>He <span id="yui_3_13_0_1_1398869179667_8626">also addresses IP protection issues, advises start-ups, </span><span id="yui_3_13_0_1_1398869179667_8603">and has appeared before an FDA Advisory Board in Washington, D.C.</span></em></span></div>
<span id="yui_3_13_0_1_1398869179667_8598" style="color: black; font-family: Arial, ' Helvetica', ' sans-serif'; font-size: 16pt;">
</span></div>
</td></tr>
</tbody></table>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-54600528272210743052014-04-30T08:05:00.001-07:002014-04-30T08:09:25.950-07:00Growing a Life Science industry in Las Vegas is achievable. <span style="background-color: white; font-family: Georgia, Times New Roman, serif; font-size: large;">Ross Newman will speak at the September 11, 2013 NevBio luncheon. He believes that if a biotech industry is going to be created in Las Vegas it will need: </span><br />
<span style="font-family: Georgia, Times New Roman, serif;"><span style="font-size: large;"><br /></span>
</span><br />
<div id="yui_3_13_0_1_1398869179667_6684" style="background-color: white;">
<div id="yui_3_13_0_1_1398869179667_6732">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;"><span id="yui_3_13_0_1_1398869179667_6731">1) Commitment </span><span id="yui_3_13_0_1_1398869179667_6733">- by talented and hardworking people that will ultimately benefit from a biotech industry</span>:</span></div>
<div id="yui_3_13_0_1_1398869179667_6734">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;"><span id="yui_3_13_0_1_1398869179667_6855">*S</span>cientists</span></div>
<div id="yui_3_13_0_1_1398869179667_6836">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;"><span id="yui_3_13_0_1_1398869179667_6856">*P</span>hysicians</span></div>
<div id="yui_3_13_0_1_1398869179667_6773">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;">*<span id="yui_3_13_0_1_1398869179667_6857">Lawyers</span></span></div>
<div id="yui_3_13_0_1_1398869179667_6772">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;"><span id="yui_3_13_0_1_1398869179667_6858">*</span><span id="yui_3_13_0_1_1398869179667_6771">Experienced Management personnel in pharma/biotech</span></span></div>
<div id="yui_3_13_0_1_1398869179667_6775">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;">*<span id="yui_3_13_0_1_1398869179667_6776">Regulatory & </span>C<span id="yui_3_13_0_1_1398869179667_6920">linical </span><span id="yui_3_13_0_1_1398869179667_6774">study </span>management</span></div>
<div id="yui_3_13_0_1_1398869179667_6912">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;">2) Risk Capital & equit<span id="yui_3_13_0_1_1398869179667_6911">y man hours </span></span></div>
<div id="yui_3_13_0_1_1398869179667_6835">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;">3) Faith (not hope)</span></div>
<div id="yui_3_13_0_1_1398869179667_6835">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;"><br /></span></div>
<div id="yui_3_13_0_1_1398869179667_6835">
<span style="font-family: Georgia, Times New Roman, serif; font-size: large;">Join us for this discussion on the future of biotechnology in Las Vegas.</span></div>
</div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1tag:blogger.com,1999:blog-6529035149852332300.post-63397933504339835192014-04-30T07:53:00.000-07:002014-04-30T08:00:34.086-07:00Ross Newman, CEO of Innovative Health Research to Speak on the Creation of a Biotech Cluster in Southern Nevada<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYOi14m6dnNraan9uLDD-K3RsRvS93BshDumnKKsGV-Kzrf3OtfUujxuh5Db21sSeiP47ckFWIovcjfHSLCjaZlr0ZGjbsBD3LuP_DhPIiYzTN990yusINEGewv-6vIqi6mv1Ke59IgF0/s1600/Ross+Newman.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYOi14m6dnNraan9uLDD-K3RsRvS93BshDumnKKsGV-Kzrf3OtfUujxuh5Db21sSeiP47ckFWIovcjfHSLCjaZlr0ZGjbsBD3LuP_DhPIiYzTN990yusINEGewv-6vIqi6mv1Ke59IgF0/s1600/Ross+Newman.jpg" /></a></div>
<div class="MsoNormal">
<span style="font-size: large;"><span style="background-color: white; font-family: Arial, sans-serif; line-height: 115%;">Ross</span> W. Newman<span id="yui_3_13_0_1_1398869179667_6777"> will speak at the NevBio meeting on September 11, 2013. He began his
30+ year career in pharmaceutical/biotech research working as a West
Coast correspondent of the investment banking firm Allen & Co. In that
role, he directed capital into-and sat on the board of directors of-many early
biotech start-ups developed from research coming out of the University of
California, San Francisco and Stanford University. </span><span style="background-color: white; font-family: Arial, sans-serif; line-height: 115%;">As one of the start-ups was
failing, he was selected by the board to become the company's new CEO. </span>Newman<span id="yui_3_13_0_1_1398869179667_6785"> was just in his 20's when he
directed the shut-down and merger into Xoma, Inc. of one of the first
monoclonal antibody companies in the country to go into clinical trials and
fail.</span><span style="font-family: Arial, sans-serif; line-height: 115%;"> <span style="background: white;">Early in his
career, he lost a couple million dollars of his own money (most of which was
borrowed, he says) and close to $20 million of investor money. It took until
1996 to pay off his debt.</span></span> <span style="background-color: white; background-position: initial initial; background-repeat: initial initial;">Newman</span><span id="yui_3_13_0_1_1398869179667_6808"> earned a BA in
Political Demography from the University of California, Berkeley in 1971. After
graduating, he traveled. In 1973, he returned to Berkeley where he completed
his doctoral dissertation in epistemology in 1977.</span></span><br />
<div class="MsoNormal">
<o:p></o:p></div>
<br />
<span style="font-family: Arial, sans-serif; line-height: 115%;"><span style="background-color: white;"><span style="font-size: large;"><br /></span></span></span>
<br /></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1tag:blogger.com,1999:blog-6529035149852332300.post-48194871157997996182013-07-14T20:40:00.001-07:002013-07-14T20:40:10.601-07:00Patent Attorney, Seaton Currran to Speak at August 8th, 2013 NevBio Luncheon<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijHzfz6tEBs9Q216rrR1qElSr9sSTv0usoVwgGrl-XmF6brv4LsD14vKOJLwqLDPyPvy5AVGmMhnprcVma0vVoIHM5ddgHQejTuyPWxUNIP1CMUHetRdTzfHWe6j2CPZpLf77u5woPqvs/s1600/seaton+curran.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijHzfz6tEBs9Q216rrR1qElSr9sSTv0usoVwgGrl-XmF6brv4LsD14vKOJLwqLDPyPvy5AVGmMhnprcVma0vVoIHM5ddgHQejTuyPWxUNIP1CMUHetRdTzfHWe6j2CPZpLf77u5woPqvs/s1600/seaton+curran.jpg" /></a></div>
<div id="yui_3_7_2_1_1373858468668_5336" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span id="yui_3_7_2_1_1373858468668_5335" style="font-size: 16pt;">Seaton Curran, J.D., MBA & P.E. of </span><span style="font-size: 16pt;">Howard & Howard will speak on </span></div>
<div id="yui_3_7_2_1_1373858468668_5348" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span id="yui_3_7_2_1_1373858468668_5347" style="font-size: 16pt;">"New Laws - New Strategy: How the Recent Changes in Patent Law Affect your IP Strategy", </span><span style="font-size: 16pt;">Thursday, August 8th, </span><span style="font-size: 16pt;">11:30 am check-in, 12 lunch & talk, </span><span style="font-size: 16pt;">McCormick & Schmicks, </span><span style="font-size: 16pt;">$30. </span><span style="font-size: 16pt;">(Students & researchers are free)</span></div>
<div id="yui_3_7_2_1_1373858468668_5348" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span style="font-size: 16pt;"><br /></span></div>
<div id="yui_3_7_2_1_1373858468668_5348" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span id="yui_3_7_2_1_1373858468668_5382" style="font-size: 16pt;">This year, the most significant changes in patent law in over 50 years went into effect as the America Invents Act continues to be implemented. As these new laws come into effect, businesses and inventors need to reevaluate their Intellectual Property strategies to adjust to the new changes. The most significant change was implemented in March 16, 2013 when the Patent system changed from "First to invent" to "First Inventor to File". Mr. </span><span id="yui_3_7_2_1_1373858468668_5384" style="font-size: 16pt;">Curran</span><span id="yui_3_7_2_1_1373858468668_5385" style="font-size: 16pt;"> will discuss IP strategy and how the new patent laws affect the protection of your intellectual property.</span></div>
<div id="yui_3_7_2_1_1373858468668_5348" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
</div>
<div id="yui_3_7_2_1_1373858468668_5348" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhozPV_6KNLflLSj0q3z-N5DF1r-8bxBFe9ea0iuMfT5gCwbZ07XQtf_4mEnxwcBX9X32-S4yN-yTlfB1eq17iAZI1PegSqn95uLCUKH2ZhwCkmKzeN0ThdoGrXEAMJfKLOOjvJFyefXLI/s1600/Howard+&+Howard.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhozPV_6KNLflLSj0q3z-N5DF1r-8bxBFe9ea0iuMfT5gCwbZ07XQtf_4mEnxwcBX9X32-S4yN-yTlfB1eq17iAZI1PegSqn95uLCUKH2ZhwCkmKzeN0ThdoGrXEAMJfKLOOjvJFyefXLI/s1600/Howard+&+Howard.jpg" /></a></div>
<div id="yui_3_7_2_1_1373858468668_5396" style="padding: 0px;">
<span id="yui_3_7_2_1_1373858468668_5395">Mr. <span id="yui_3_7_2_1_1373858468668_5403">Curran</span> is an attorney with the law firm of Howard & Howard and concentrates his practice on intellectual property. He advises clients in the development intellectual property strategies with a focus on maximizing business value through the protection and licensing of business assets. He concentrates his practice in the area of patent law with experience in mechanical, electrical and computer software technologies, and assists client with the preparation and prosecution of U.S. and foreign patent applications, trademark registrations, patentability searches, patent landscape analysis, freedom-to-operate, infringement analyses and invalidity opinions. Mr. <span id="yui_3_7_2_1_1373858468668_5413">Curran</span> received his J.D. from the University of Nevada Las Vegas, M.B.A. from the University of Southern California, and BS in engineering from Loyola Marymount University. He is licensed to practice in Nevada and before the USPTO, and holds a professional engineering license in Nevada.</span></div>
<div id="yui_3_7_2_1_1373858468668_5396" style="padding: 0px;">
<span><br /></span></div>
<div id="yui_3_7_2_1_1373858468668_5426">
Seaton Curran has presented to NevBio before. He gives an exceptional presentation. I would advise you not to miss his talk.</div>
<div id="yui_3_7_2_1_1373858468668_5425">
</div>
<div id="yui_3_7_2_1_1373858468668_5424">
<b>Sincerely,</b></div>
<div id="yui_3_7_2_1_1373858468668_5423">
</div>
<div id="yui_3_7_2_1_1373858468668_5422">
John Laub</div>
<div id="yui_3_7_2_1_1373858468668_5421">
Nevada Biotechnology & Health Science Consortium</div>
<div id="yui_3_7_2_1_1373858468668_5420">
jlaub@regenmd.org</div>
</div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-20694636128663396192013-07-14T20:28:00.002-07:002013-07-14T20:28:30.579-07:00Dr. Ron Kline, Pediatric Oncologist to Speak on the Health Insurance Exchange on July 12, 2013<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBiEiyzAtrtfQwuIhyphenhyphenIoBvYW_GFkLKF43oaChTozJaEorEeva-fEew60YNFtEFpFy1MnWqmvUEMa5X2NYbwjL8P_-_3N6XlSUbZDqId8NA6tU-z982VtlXyD7_Q47_gFIqmHo_ulrblIs/s1600/Ron+Kline+MD.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBiEiyzAtrtfQwuIhyphenhyphenIoBvYW_GFkLKF43oaChTozJaEorEeva-fEew60YNFtEFpFy1MnWqmvUEMa5X2NYbwjL8P_-_3N6XlSUbZDqId8NA6tU-z982VtlXyD7_Q47_gFIqmHo_ulrblIs/s1600/Ron+Kline+MD.jpg" /></a></div>
<div id="yui_3_7_2_1_1373858468668_4807" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span id="yui_3_7_2_1_1373858468668_4806" style="font-size: 16pt;">Dr. Ron Kline will speak on </span><span style="font-size: 16pt;">"Nevada's Health Insurance Exchange -</span></div>
<div id="yui_3_7_2_1_1373858468668_4803" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span id="yui_3_7_2_1_1373858468668_4802" style="font-size: 16pt;">A Doctor's Point of View" </span><span style="font-size: 16pt;">Friday, July 12th, </span><span style="font-size: 16pt;">11:30 Check-in, 12 noon lunch & talk </span><span style="font-size: 16pt;">McCormick & Schmicks.</span></div>
<div id="yui_3_7_2_1_1373858468668_4803" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<span style="font-size: 16pt;"><br /></span></div>
<div id="yui_3_7_2_1_1373858468668_4803" style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 21px; text-align: left;">
<div id="yui_3_7_2_1_1373858468668_4835" style="padding: 0px;">
Ronald Kline is a pediatric hematologist-oncologist and pediatric bone marrow transplant physician. </div>
<div id="yui_3_7_2_1_1373858468668_4845" style="padding: 0px;">
<br /></div>
<div id="yui_3_7_2_1_1373858468668_4847" style="padding: 0px;">
<span id="yui_3_7_2_1_1373858468668_4846">In 2011 he was appointed by Governor Sandoval to the Board of Directors of the Silver State Health Insurance Exchange.</span></div>
<div style="padding: 0px;">
<br /></div>
<div id="yui_3_7_2_1_1373858468668_4849" style="padding: 0px;">
<span id="yui_3_7_2_1_1373858468668_4848">Dr. Kline is the author of 20 scientific articles, as well as the editor of a textbook on pediatric bone marrow transplantation</span> </div>
<div id="yui_3_7_2_1_1373858468668_4850" style="padding: 0px;">
<br /></div>
<div id="yui_3_7_2_1_1373858468668_4852" style="padding: 0px;">
<span id="yui_3_7_2_1_1373858468668_4851" style="font-size: 16pt;"><img align="right" border="0" height="24" hspace="5" name="ACCOUNT.IMAGE.1248" src="http://ih.constantcontact.com/fs117/1102064778863/img/1248.jpg" style="border: 0px;" vspace="5" width="69" />He earned his medical degree from UCLA. His postgraduate clinical training was at the Children's Hospital of Los Angeles and UCSF. In addition, he completed a research fellowship at the National Cancer Institute, publishing work on the immunotherapy of cancer.</span></div>
<div id="yui_3_7_2_1_1373858468668_4865" style="padding: 0px;">
<br /></div>
<div id="yui_3_7_2_1_1373858468668_4855" style="padding: 0px;">
He was the President of the Clark County Medical Society. </div>
<div id="yui_3_7_2_1_1373858468668_4856" style="padding: 0px;">
He was the President of the Nevada State Me<span id="yui_3_7_2_1_1373858468668_4857" style="font-size: 16pt;">dical Association.</span></div>
<div id="yui_3_7_2_1_1373858468668_4856" style="padding: 0px;">
<span style="font-size: 16pt;"><br /></span></div>
<div id="yui_3_7_2_1_1373858468668_4858" style="padding: 0px;">
<br /></div>
<div id="yui_3_7_2_1_1373858468668_4854" style="padding: 0px;">
<img align="right" alt="CCCN" border="0" height="71" hspace="5" id="yui_3_7_2_1_1373858468668_4853" name="ACCOUNT.IMAGE.821" src="http://ih.constantcontact.com/fs069/1102064778863/img/821.jpg" style="border: 0px;" vspace="5" width="82" />He is a doctor with Comprehensive Cancer Centers of Nevada and has lived in Las Vegas for 10 years.</div>
<div id="yui_3_7_2_1_1373858468668_4854" style="padding: 0px;">
<br /></div>
<table border="0" cellpadding="5" cellspacing="0" id="yiv8711685155content_LETTER.BLOCK9" style="color: #454545; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 12px; margin-bottom: 5px; padding: 0px; width: 100%px;"><tbody id="yui_3_7_2_1_1373858468668_4825" style="width: 385px;">
<tr id="yui_3_7_2_1_1373858468668_4824"><td align="left" colspan="1" id="yiv8711685155evm-content-maintext2" rowspan="1" style="border-spacing: 2px; color: black; font-family: Arial, Helvetica, sans-serif; font-size: 16pt;"><div id="yui_3_7_2_1_1373858468668_4828">
Come hear an in-depth explanation of the new Silver State Health Insurance Exchange that will be starting enrollment on October 1st for coverage to start on January 1, 2014. </div>
<div id="yui_3_7_2_1_1373858468668_4876">
Dr. Ron Kline is a past president of the Clark County Medical Society and the Nevada State Medical Association and is now a Director of the Silver State Health Exchange.</div>
</td></tr>
</tbody></table>
<table border="0" cellpadding="5" cellspacing="0" id="yiv8711685155content_LETTER.BLOCK8" style="color: #454545; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 12px; margin-bottom: 5px; padding: 0px; width: 100%px;"><tbody id="yui_3_7_2_1_1373858468668_4879" style="width: 385px;">
<tr id="yui_3_7_2_1_1373858468668_4878"><td align="left" colspan="1" id="yiv8711685155evm-content-maintext2" rowspan="1" style="border-spacing: 2px; color: black; font-family: Arial, Helvetica, sans-serif; font-size: 16pt;"><a class="yiv8711685155imgCaptionAnchor" href="http://r20.rs6.net/tn.jsp?e=0017TRN3BMySTqBSZWHwsUEr_3xoXPosKWnKNo_sCV1bDIzE7qYX75Bt6HbtssmtHAr67ME2tsQAyCIJxlfwdgpXQhYkdw7OpAYzjlAS7tY9eOb3DThtZO5qQ==" id="yui_3_7_2_1_1373858468668_4891" rel="nofollow" shape="rect" style="color: #2862c5; outline: 0px;" target="_blank"><img align="right" border="0" height="69" hspace="5" id="yui_3_7_2_1_1373858468668_4890" name="ACCOUNT.IMAGE.1246" src="http://ih.constantcontact.com/fs117/1102064778863/img/1246.jpg" style="border: 0px;" vspace="5" width="128" /></a><div id="yui_3_7_2_1_1373858468668_4894">
<strong id="yui_3_7_2_1_1373858468668_4893">Health Insurance Exchange Facts:</strong></div>
<div id="yui_3_7_2_1_1373858468668_4877">
* There is no delay on implementation of the</div>
<div>
requirement of health insurance by 2014</div>
<div id="yui_3_7_2_1_1373858468668_4895">
* There is no delay in implementing Nevada's Health Insurance Exchange.</div>
<div id="yui_3_7_2_1_1373858468668_4896">
* There is a delay for the large employer mandate to 2015 but it does not affect the Insurance Exchange</div>
<div id="yui_3_7_2_1_1373858468668_4897">
* There are 588,000 Nevadans that don't have health insurance.</div>
<div id="yui_3_7_2_1_1373858468668_4889">
* Nevadans will be penalized in 2014 for not having health care.</div>
<div>
<span style="font-size: 16pt;">* Enrollment for the exchange starts on October 1st for coverage on January 1st.</span></div>
<div id="yui_3_7_2_1_1373858468668_4902">
</div>
<div id="yui_3_7_2_1_1373858468668_4880">
The Affordable Care Act will change health care. It will affect the medical industry. Ron Kline is one of the Directors of the Health Insurance Exchange in Nevada. He was also <img align="right" border="0" height="64" hspace="5" id="yui_3_7_2_1_1373858468668_4898" name="ACCOUNT.IMAGE.1247" src="http://ih.constantcontact.com/fs117/1102064778863/img/1247.jpg" style="border: 0px;" vspace="5" width="101" />awarded a fellowship from the Robert Wood Johnson Foundation. Don't miss this opportunity to learn about the changes that are coming. </div>
</td></tr>
</tbody></table>
</div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-74894811541913189612013-05-28T22:09:00.002-07:002013-05-28T22:09:27.343-07:00Dr. Craig Dees, CEO of Provectus - Promising Results in Phase II for Melanoma - June 5, 2013<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9anwHHoDRxSbAoEiLtV2PGaTqvupa9hpi9jr56eA7CkabFMYBjHBoRWfpjKJ_Ssjec2t9x5wHyMgHtcTpJXvfOQuEYf8Pl5wMDr9Agubj9cW7o76aVPfb1FLfdD7aXoC3qgJEPS4_4tU/s1600/Dr.+Craig+Dees+2.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9anwHHoDRxSbAoEiLtV2PGaTqvupa9hpi9jr56eA7CkabFMYBjHBoRWfpjKJ_Ssjec2t9x5wHyMgHtcTpJXvfOQuEYf8Pl5wMDr9Agubj9cW7o76aVPfb1FLfdD7aXoC3qgJEPS4_4tU/s200/Dr.+Craig+Dees+2.jpg" width="172" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Please
join us - NevBio evening event:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dr.
Craig Dees, CEO of Provectus Pharmaceuticals, Inc.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">"Promising
Results with Melanoma Lesions in Phase II Trial of 80 subjects"<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Wednesday,
June 5th, 5:30 pm<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Panevino
Restaurant (New location)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">RSVP
here. $10 (Students, researchers & anyone involved in cancer - no charge)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Provectus
Pharmaceuticals, Inc.is an oncology and dermatology biopharmaceutical company
which is conducting Phase 2 trials of its drug, PV-10 as a treatment for
metastic melanoma. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">PV-10
selectively destroys cancer cells without harming surrounding healthy tissue.
As reported in Practical Dermatology, the phase II open label, single-arm
trial, 80 subjects with AJCC Stage III/ IV melanoma received treatment for one
to 10 target lesions and up to 10 non-target lesions; at least one target
lesion had to have biopsy confirmation of the diagnosis. Target lesions were
>0.2cm diameter. Intralesional dosing was provided at 50 percent of the
calculated lesion volume. Retreatment was allowed at weeks 8, 12, or 16, and
all subjects were followed for 52 weeks. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">According
to final outcome data provided by Provectus, a Complete Response (CR: complete
disappearance of the tumor) of PV-10 injected lesions was achieved in 26
percent of subjects, Partial Response (PR: at least a 30 percent reduction in
tumor volume) was seen in 25 percent of subjects, and Stable Disease (SD: less
than 20 percent increase in tumor volume) was seen in 18 percent of subjects.
Less than one-third (31 percent) of subjects experienced Disease Progression
(DP: 20 percent or greater increase in tumor volume).<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dr.
Craig Dees & Provectus have had impressive results from their Phase 2 study
and are preparing for Phase 3.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">We
want to thank Dominic Rodrigues for generously supporting the effort to have
Dr. Dees speak in Las Vegas. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">There's
a lot more to the story of Dr. Dees & Provectus. I hope you can join us on
Wednesday, June 5th. <o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com11tag:blogger.com,1999:blog-6529035149852332300.post-22807896745686895802013-05-28T21:57:00.002-07:002013-05-28T21:57:58.021-07:00 Cord Blood America - Saving the Lives of the those Closest to You - May 17, 2013<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgVwW3bzGH_taN4KjRCWg-EyB8EIMxzvUnKot97Ks2TxC9mrcUDXhmibeMV_-P-ifoFUYDbvUBf0mQoggITXU72r4dIrV6EkOEEItavv68xt8Zsrb-O1MkFARdROXUxan1vXmxnNSGBDjs/s1600/Cord+Blood.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgVwW3bzGH_taN4KjRCWg-EyB8EIMxzvUnKot97Ks2TxC9mrcUDXhmibeMV_-P-ifoFUYDbvUBf0mQoggITXU72r4dIrV6EkOEEItavv68xt8Zsrb-O1MkFARdROXUxan1vXmxnNSGBDjs/s1600/Cord+Blood.jpg" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Join
us CEO of Cord Blood America, <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Joseph
Vicente & Dr. Geoffrey O'Neill<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Date: Friday, May 17th <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">11:30
am check-in, 12 noon lunch/talk<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Place:
McCormick & Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Cost:
$30 here. (Students & Researchers are free)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Joseph
R. Vicente, has been the Chairman and President at Cord Blood America Inc.
since May 15, 2012. Mr. Vicente had served as the Chief Operating Officer/VP
and as the VP of Corporate Strategy at Cord Blood America Inc. He had earlier
co-founded The Empower Network, Inc. He served as the President and Chief
Operating Officer of The Empower Network, Inc. Joe has been a Director of Cord
Blood America Inc. since June 2004. He earned an MBA from the University of
Tampa.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dr.
Geoffrey O'Neill, who will also be speaking, has 25 years experience in the
stem cell industry, has published 78 papers on the sector. He was the recipient
of the prestigious Jean Julliard Price for Research from the International
Society of Blood Transfusion and the International Society of Hematology.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> Cord Blood America preserves cord blood at the
birth of a child for potential use in future stem cell therapy. The umbilical
cord contains a rich store of stem cells.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Cryogenically
preserved umbilical cord stem cells have already been used to treat 75 major
diseases: leukemia, severe anemia, metabolic blood disorders, immune deficiencies and seventy other
diseases.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-54917359687884417882013-05-28T21:49:00.000-07:002013-07-29T09:06:50.703-07:00NevBio Luncheon - Van Vo, Cancer Researcher at UNLV on April 30, 2013<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="MsoNoSpacing">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhQaSDq5qQlHOe2UybDXuSoU2V-c_7hsjUWPwGG6M9qRGiSGHXYbZ53oL3HaWEP3mPfZ34DPD38lptQQ30T_aCwZIhdBl6JKqhrrzlFqA5dKVr9FyElB5xjmQhR6pZ4tgMfZlUBv7RnGQo/s1600/Cancer.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="110" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhQaSDq5qQlHOe2UybDXuSoU2V-c_7hsjUWPwGG6M9qRGiSGHXYbZ53oL3HaWEP3mPfZ34DPD38lptQQ30T_aCwZIhdBl6JKqhrrzlFqA5dKVr9FyElB5xjmQhR6pZ4tgMfZlUBv7RnGQo/s320/Cancer.jpg" width="320" /></a></div>
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Van
Vo, Cancer Researcher at UNLV<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Tuesday,
April 30th<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">McCormick
& Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">11:30
am check-in, 12 noon lunch & talk<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">RSVP
here. $30. Students & researchers, no cost.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Van
Vo is a PhD candidate at UNLV. Her research involves developing cisplatin
analogues for the treatment of cancer<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
In Vitro Cytotoxic Effects of Cisplatin Analogues in Cancer and Normal Cells by
Van Vo, Ontida Tanthmanatham, Haesook Han, Pradip K. Bhowmik and Bryan L.
Spangelo, UNLV Department of Chemistry<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">About
50% of cancer chemotherapeutic regimens consist of platinum-based drugs.
Cisplatin (CDDP) was the first platinum(II) complex approved for clinical
treatment by the U.S. Food and Drug Administration (FDA) in 1978. Along with
cisplatin, two other platinum(II) complexes, carboplatin and oxaliplatin, are
now approved for use worldwide. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Although
commonly prescribed, clinical application of platinum drugs is limited due to
narrow spectra of activity, cellular resistance, and toxic side effects. As a
consequence of <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">these
drawbacks, the search for improved drugs continues with the goal of discovering
compounds with greater efficacy and reduced toxicity. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Cisplatin
is not routinely used for the treatment of breast cancer since many breast
cancers are resistant to cisplatin treatment; however, it has been reported
that some breast <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">cancers
are sensitive to cisplatin. In an effort to develop improved platinum drugs for
the treatment of breast cancers, new platinum-complexes have been synthesized. <o:p></o:p></span></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> In vitro studies in various human breast
cancer cells demonstrated that these compounds are much more potent than
cisplatin. One of the synthesized complexes was also tested in a normal human
breast cell line and was found to be more toxic to the normal cells compared to
cancer cells. However, when this compound was tested in vivo in a mouse model,
the animals survived after administration of the compound at a dose of 12.5
mg/kg/day for three days. Further studies are required to assess the potential
translation of these compounds into clinical use.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com2tag:blogger.com,1999:blog-6529035149852332300.post-19286879302874793852013-05-28T21:37:00.000-07:002013-07-29T09:09:19.143-07:00Crohn's Disease & Ulcerative Colitis at NevBio - Thurs, April 25, 2013<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Thursday,
April 25th, 12 Noon<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Glenn
Diamond, Red Green Biotechnology<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> McCormick & Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">11:30
Check-in, 12 pm lunch & talk.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">$30.
(students & researchers free)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="MsoNoSpacing">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhXazveI65m80KJnRAOgvsMHCUf_kg1tv1pN5ifPfXwe_7jNXfr5lbauoDMyHLiAgI8mJUoKJbcuIbXns1UnXRvIP8EzYP4r3RbD3CKHaRKwYmj3UYrJHtVmK9EsV7effW_WTJmpNfR5UU/s1600/Crohns.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="70" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhXazveI65m80KJnRAOgvsMHCUf_kg1tv1pN5ifPfXwe_7jNXfr5lbauoDMyHLiAgI8mJUoKJbcuIbXns1UnXRvIP8EzYP4r3RbD3CKHaRKwYmj3UYrJHtVmK9EsV7effW_WTJmpNfR5UU/s400/Crohns.jpg" width="400" /></a></div>
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">"Crohn's
Disease & Ulcerative Colitis" <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Red
Green Biotechnology launch against inflammatory bowel disease epidemic.
Innovate Nevada's first parade entrepreneur.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Glenn
Diamond is the Founder of Neuropeptide Dynamics and David Pharmaceuticals. He
is a polymath featured in Fortune (see article on left) for smart drug
development work. One of the last disciples of Bob Swanson immortal founder of
Genentech and the world's biotechnology industry.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Over
700,000 Americans have Crohn's Disease. It generally strikes individuals
between 15 and 35. Crohn's disease belongs to a group of conditions known as
Inflammatory Bowel Diseases (IBD). Crohn's disease is a chronic inflammatory
condition of the gastrointestinal tract.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Crohn's
most commonly affects the end of the small bowel (the ileum) and the beginning
of the colon, but it may affect any part of the gastrointestinal (GI) tract,
from the mouth to the anus. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">There
is no known cure.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Who
is Glenn Diamond? <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">From
Fortune Magazine:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">"Perhaps
the most remarkable member of the damn-the-torpedoes set is Glenn
"Buddy" Diamond, an entrepreneur who set out six years ago to
mitigate his son's Down syndrome. That congenital disorder causes not only
retardation but also progressive brain damage much like that of Alzheimer's.
Starting with zero funding and no drug industry experience, Diamond managed to
light a fire under the development of both the Russian and the Novartis drugs,
enlist some of biotech's leading lights to back his cause, and inspire the
formation of David Pharmaceuticals--the startup is named after his 9-year-old
son.<o:p></o:p></span></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Known
to associates as a brilliant, uncompromising polymath, Diamond was a
Minneapolis consultant on business turnarounds when David was born. He soon
became a self-taught expert on Down syndrome." See rest of the story here. (Glenn's story
starts on the 22nd paragraph.)<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com3tag:blogger.com,1999:blog-6529035149852332300.post-24679705867617754542013-05-27T22:17:00.000-07:002013-05-27T22:17:23.098-07:00NevBio Commercialization Briefing -New Opportunities for Southern Nevada - February 22, 2013<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Join
us and take part as we reshape Southern Nevada with new opportunities.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Friday,
February 22nd<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">McCormick
& Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">11:30
am reg, 12 pm lunch & briefs<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">RSVP
Free here ($30 normal charge)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Marty
Schiller, PhD, UNLV; Treating HIV/Aids and other diseases with Genomic Surgery
(New base of biotechnology, hundreds of job, $ billion market). SciReader - an
app that can be used by every STEM student in the world. Huge potential.</span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj7wHb4gRLbGJPrKk8k5iPL3Z_3tVVSEAm0mkP5pCRm_u24OnGQ4HDnLbtpUAlq9dTn1CYZaItdrZ_z9IpLOXgOTb9BAgP9w0-cx3hNfX0p0VUxjPLYr-nieNaa63Tadz_3DnfTS5cYV7I/s1600/Francis+Tsang.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj7wHb4gRLbGJPrKk8k5iPL3Z_3tVVSEAm0mkP5pCRm_u24OnGQ4HDnLbtpUAlq9dTn1CYZaItdrZ_z9IpLOXgOTb9BAgP9w0-cx3hNfX0p0VUxjPLYr-nieNaa63Tadz_3DnfTS5cYV7I/s1600/Francis+Tsang.jpg" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Francis
Tsang, PhD, National Labs, Medical Isotopes (The US imports all of its medical
isotopes. $1 billion industry in the US, thousands of job in Nevada.) E-beam
for cancer tumors can be used in every cancer center in the world. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"><br /></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Ernest
Abel-Santos, PhD, UNLV; Treatment to prevent for C-Diff infections. Needed in
every hospital, clinic and nursing home - $ billion market.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Opportunities
like this, raise all of the boats. This is an important step toward new,
home-grown industry in Southern Nevada.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-4737058181142399542013-05-27T22:09:00.000-07:002013-05-27T22:09:13.711-07:00Tech Transfer in the University System - Rich Helfrich, December 11, 2012<table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2HdlThWhaxjOSZXmnvy02xbk0cVmFlP7onVROjjz5NJ3yM7xOjPb4MNTIqSPdzs72QyDxPY6oLtH44m8l7lbm2DGP1cDQkrZhkOC0WJ0GMhH5oBUxmlnVLO3TGDUx0_OJEQBahRSeKEw/s1600/Richard+Helfrich.jpg" imageanchor="1" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2HdlThWhaxjOSZXmnvy02xbk0cVmFlP7onVROjjz5NJ3yM7xOjPb4MNTIqSPdzs72QyDxPY6oLtH44m8l7lbm2DGP1cDQkrZhkOC0WJ0GMhH5oBUxmlnVLO3TGDUx0_OJEQBahRSeKEw/s1600/Richard+Helfrich.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Rich Helfrich</td></tr>
</tbody></table>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Richard
Helfrich, CEO of Alameda Advisors "Converting Innovations to Sustainable
Businesses"<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*Tuesday,
December 11th<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*11:30
check-in,12 pm lunch/talk *MCormick & Schmicks <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*$30
RSVP here. UNLV Researchers & students - no cost.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Richard
W. Helfrich is the President of Alameda Advisors. His team has helped
commercialize innovations from universities, government labs and corporations,
converting complex technology and life science ideas into businesses.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> Richard is an entrepreneur. He has started a
number of companies. One of his startups is on NASDAQ. He sits on a number of boards in advanced
materials, alternative energy, semiconductors, medical, and communications
hardware.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">He
has an AB degree in Physics, an MS in Electrical Engineering and a premed
education covering chemistry & biochemistry.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Richard
Helfrich supports improving economic growth and the quality of life through
technology and a technology- savvy workforce. Richard supports programs for
expanded K-12 science education, reduced regulatory and governance burdens for
small business, and programs to encourage more spinouts/startups from federally
funded and corporate research.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Alameda
Advisors Inc. converts innovations to sustainable businesses:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Maximizing results from intellectual property<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Converting innovations to companies via spinouts<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> * Providing Silicon Valley connections<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Arranging efficient and effective Cleantech Solutions<o:p></o:p></span></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
company "Converts innovations to Profits".<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-42383181258272979472013-05-27T22:02:00.001-07:002013-05-27T22:02:33.961-07:00Attend University of Nevada School of Medicine, Dean Thomas Schwenk - February 13, 2013<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhxOtgYlmBlFW_woQYhqSAl-2gMCCCliV0Botspdvb-R4NfcMDguYhw7Iq5ldYICMdDxD9287nt8OmgYBN615n4WI1byIXGVt_taVinicfCbbElQrm9U6suOOxVHLMNbZjXZOOvJ1ppRic/s1600/Thomas+Schwenk+4.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhxOtgYlmBlFW_woQYhqSAl-2gMCCCliV0Botspdvb-R4NfcMDguYhw7Iq5ldYICMdDxD9287nt8OmgYBN615n4WI1byIXGVt_taVinicfCbbElQrm9U6suOOxVHLMNbZjXZOOvJ1ppRic/s1600/Thomas+Schwenk+4.jpg" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Nevada
Biotechnology & Health Science Consortium and Southern Nevada Medical
Industry Coalition present<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dr.
Thomas Schwenk, Dean of the University of Nevada School of Medicine<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Date:
Wednesday, February 13th<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Time:
11:30 reg, 12 pm lunch<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Cost:
$30<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Location:
Fogo de Chao (new location)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Thomas
L. Schwenk, M.D., is dean of the University of Nevada School of Medicine.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Schwenk
earned his M.D. degree in 1975 from the University of Michigan Medical School.
In 2002 he was elected to the Institute of Medicine of the United States
National Academy of Sciences. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">His
research focuses on the diagnosis and treatment of depression in primary care. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Schwenk
spent much of his career at the University of Michigan. He joined the faculty
of the Department of Family Medicine in 1984, was appointed interim chair of
the department in 1986, and was named permanent chair in 1988. He also served
as a professor in the Department of Medical Education and as associate director
of the University of Michigan Depression Center. In June 2007 he was installed
as the Chair of Family Medicine. In July 2011 Schwenk left Michigan to become
dean of the University of Nevada School of Medicine.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
luncheon will be at a new location!<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Fogo
de Chao 360 E. Flamingo (Right next to McCormick & Schmicks). We have over
90 attending this joint meeting. Please get there early.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Southern
Nevada Medical Industry Coalition is co-hosting. It is a non-profit 600-plus
volunteer organization of healthcare professionals committed to improving
access and delivery of medical care in Southern Nevada. <o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-88195129185512978382013-05-27T21:54:00.002-07:002013-05-27T21:54:55.768-07:00Chancellor Dan Klaich & Former Jim Rogers - January 22, 2013<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhrlLkDMcKvu7In893UROtUg2mMjZLZvet8wGS97yykeFmrvXa18BzprDBxeX2SlT-BiheN1yIOqnSK_g9Hl5ljkOrGqmWM5KtcvWRKwjTY-h02eSdlkXlecxCEha1WVKL76lpbbsKZ7zc/s1600/Jim+Rogers+1.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhrlLkDMcKvu7In893UROtUg2mMjZLZvet8wGS97yykeFmrvXa18BzprDBxeX2SlT-BiheN1yIOqnSK_g9Hl5ljkOrGqmWM5KtcvWRKwjTY-h02eSdlkXlecxCEha1WVKL76lpbbsKZ7zc/s1600/Jim+Rogers+1.jpg" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Please
join us for Dan Klaich, Chancellor of the Nevada System of Higher Education
(NSHE) & Jim Rogers, former Chancellor of NSHE<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">DATE:
Tuesday, January 22nd<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">LOCATION:
McCormick & Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">CHECK-IN:
11:30 am, Lunch 12 noon<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">RSVP:
Here. $30 (UNLV Researchers & Students no charge)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgjD7BHSoLljljW11o-wlVDYfDlG5rDG9URjFXVKC7t3rUpXacEG8G4AEneQPlSTeGPViOXLmMy6Ojplkxzt-TJkGE9tqghu0KrMSpFnedvuTTRoSHeLkfiAXPGDcZ5-1mkwHgt7maB2fU/s1600/Klaich.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgjD7BHSoLljljW11o-wlVDYfDlG5rDG9URjFXVKC7t3rUpXacEG8G4AEneQPlSTeGPViOXLmMy6Ojplkxzt-TJkGE9tqghu0KrMSpFnedvuTTRoSHeLkfiAXPGDcZ5-1mkwHgt7maB2fU/s200/Klaich.jpg" width="147" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Chancellor
Klaich will talk about a number of issues:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Fair funding of higher education in Southern & Northern Nevada<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Vision for Higher Education in Nevada.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
The UNLV Events Center.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Greater presence of School of Medicine in Southern Nevada.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Jim
Rogers will talk about:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Need for research<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">*
Serving a diverse student population<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">In
May 2004, Jim Rogers was appointed to serve as the Chancellor of the Nevada
System of Higher Education. Jim served as the Chancellor through June 2009.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">In
1999 Jim was listed as one of the "top 11 philanthropists in the
nation" by Time magazine having given or pledged more than $275 million to
various colleges and universities.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Jim
earned a B.S. in accounting and an LL.B. from the University of Arizona and an
LL.M. from the University of Southern California. Jim is the founder and owner
of Intermountain West Communications which owns and operates 11 NBC and FOX
affiliate TV stations in five Western states.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dan
Klaich has been the Chancellor since June 18, 2009. Previously he was vice
chancellor. Dan is an attorney. He is a 1972 graduate of the University of
Nevada, Reno with a Bachelor of Science in Accounting. He received his JD from
the University of Washington School of Law.
Dan served on the Board of Regents of the NSHE from 1983 to 1997,
including two terms as Chairman of the Board.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-17744008085823096272013-05-27T21:48:00.000-07:002013-05-27T21:48:46.643-07:00NevBio Innovation Workshop - January 4, 2013 <span style="font-family: Arial, sans-serif; font-size: 14pt;">"Five
Mistakes Entrepreneurs Make"</span><br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">with
Matthew Waymire, CPA & Business Broker.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Date:
Friday, January 4th<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Time:
11:30 Check-in, 12 pm lunch<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Location:
McCormick & Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Price:
$30 RSVP here.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">UNLV
students & researchers - free<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Matthew
Waymire, CPA has been around and studied start up businesses for 25 years. He's
one of the bright minds in this area.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
Five Mistakes:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">1.
New business ideas must be first about getting more information, i.e.,
developed the business model before writing a business plan.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">2.
You need to create multiple ways of looking at your product. You never know
which market will take off.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">3.
You need a team. Create a board of advisors.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">4.
You must develop angels & champions for your idea.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">5.
Don't under estimate the number of calls and contacts you must make to make
this idea work.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com0tag:blogger.com,1999:blog-6529035149852332300.post-42800343446949807262013-05-27T21:42:00.002-07:002013-05-27T21:42:54.566-07:00Using Magnetic Fields for Treating Disease Dr. Dean Bonlie - November 29, 2012<table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgofWla0Ovfz6GrLThIezwWMdWwyc6jPVW4OeyNbfC1WWbk75AZ_XTKnze6oywatJdxG-uV5NzNhGqiJ_DvboA_TRzdu9zBzseVgRpD8P9D2ok9I6FsdmmWwNOos6hEW9Fu6MqmLwjZOsc/s1600/Dean+Bonlie.jpg" imageanchor="1" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgofWla0Ovfz6GrLThIezwWMdWwyc6jPVW4OeyNbfC1WWbk75AZ_XTKnze6oywatJdxG-uV5NzNhGqiJ_DvboA_TRzdu9zBzseVgRpD8P9D2ok9I6FsdmmWwNOos6hEW9Fu6MqmLwjZOsc/s200/Dean+Bonlie.jpg" width="160" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Dr. Dean Bonlie</td></tr>
</tbody></table>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dr.
Dean Bonlie, Biomagnetism<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">(See
aliments below)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Date:
Thursday, November 29<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Place:
McCormick & Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Time:
Check-in 11:30 am, 12 pm lunch<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">RSVP
here. $30 All UNLV researchers & students may attend at no cost.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Research
with the Magnetic Molecular Energizer (MME) has shown promise: spinal cord
injury, brain injury, stroke impairment, multiple sclerosis, muscular
dystrophy, cerebral palsy, Parkinson's disease, Alzheimer's disease, congestive
heart failure, bone and joint repair.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">All
new ideas are controversial. New discoveries are always on the edge. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">In
the early 1990s, Dr. Dean Bonlie began studying magnetism and its effect on the
human body. <o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> He found that low strength, negative, magnetic
field induced through the body by a layer of magnets beneath the body could
provide relief from numerous symptoms, such as pain relief from arthritis and
back pain, and sleep disorders. See testimonials here.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">This
led to study and research of higher strength magnetic fields, similar to those
produced by MRI scanners, as a possible treatment method.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Research
with the Magnetic Molecular Energizer (MME) offers hope for many diseases
previously considered untreatable by conventional methods. It has thus far shown promise with a wide
variety of ailments such as spinal cord injury, brain injury, stroke
impairment, multiple sclerosis, muscular dystrophy, cerebral palsy, Parkinson's
disease, Alzheimer's disease, congestive heart failure, and orthopedic
conditions involving bone and joint repair.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;"> MME is a treatment method that consists of the
application of high (3,000 to 5,000 gauss) direct current electromagnetic
fields. An MME device consists of two
very large and strong electromagnets, with the patient lying in a focal point
between the two electromagnets.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
human body is electromagnetic, being composed largely of charged particles such
as atoms, electrons, protons, and ions (e.g. potassium, sodium, etc.). These all perform vital life functions.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
Theory behind MME treatment is as follows:<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">When
a patient is placed in the MME device there is a temporary increase in the
magnetic force on the atoms composing the cells of his/her body in the area of
the MME focal point. The force results
in a higher velocity of some of the orbiting electrons. This increase in velocity of some electrons
and not others causes precession or wobble of an atom and a higher charge on
the valence electrons. Combined, the
higher velocity and increased charge, leads to enhanced electron transfer. Electron transfer is the basic action in all
chemical reactions in the body.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">The
magnetic field of the MME device acts as a catalyst to improve chemical
reactions occurring in the human body.
This improves a variety of body functions in the area of the MME focal
point, such as oxygen carrying capacity, assimilation of nutrients, manufacture
of enzymes, metabolic waste removal, reduction of free radicals, tissue
regeneration, and most importantly healing.
The rate of healing can be accelerated to be much faster than the
typical healing rate of the human body.
For example, a bone fracture that typically requires 6-8 weeks to heal
may require only a few days with MME treatment.<o:p></o:p></span></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Dr.
Bonlie gives talks all over the country but his company, Magnetico is based in
Las Vegas.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1tag:blogger.com,1999:blog-6529035149852332300.post-34115098150236477252013-05-27T21:36:00.000-07:002013-05-27T21:36:15.968-07:00Pramod Gupta, PhD with Spectrum Pharmaceuticals - Biotech Success Story Friday, October 26, 2012<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJ3ZTyDMthFBWR7HQlLE_39-p56PIJnE7PzEvhMKOQ2puWt88YCANMT5CpX0aHmTtIILG0nvHAOOdGCm_XIG2XxP55s4Sg_xHo8UQd210aQQRGA7-_7l9If4oaX-GaVc-UCKMEFM1RgEc/s1600/Spectrum.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJ3ZTyDMthFBWR7HQlLE_39-p56PIJnE7PzEvhMKOQ2puWt88YCANMT5CpX0aHmTtIILG0nvHAOOdGCm_XIG2XxP55s4Sg_xHo8UQd210aQQRGA7-_7l9If4oaX-GaVc-UCKMEFM1RgEc/s1600/Spectrum.jpg" /></a></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Pramod
Gupta, PhD, SVP of Pharmaceutical Operations at Spectrum Pharmaceuticals will
be speaking on "Research Opportunities in Current Health Care
Environment".<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Friday,
October 26th (Nevada Day)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">11:30
check-in, 12 pm Lunch & Talk<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">McCormick
& Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">$30
RSVP here<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">(UNLV
Students & Researchers - free! Please RSVP)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Spectrum
Pharmaceuticals (SPPI) is a biotechnology company with a primary focus in
oncology and hematology. Its headquarters is in Henderson, Nevada.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Spectrum
has three oncology drugs in the market: FUSILEV® (levoleucovorin), FOLOTYN®
(pralatrexate injection) and ZEVALIN® (ibritumomab tiuxetan).<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Spectrum
has an expertise in acquiring differentiated drugs and a growing pipeline of
candidates in Phase 2 and Phase 3 trials (10 drugs in the pipeline).<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Spectrum
Pharmaceuticals is one of the fastest growing companies in biotechnology. It
has a massive pipeline, two marketed drugs, and is very cash rich. (Brian
Nichols, Sept 2, 2012 Seeking Alpha). Spectrum's revenues are expected to
increase by 50% to $300 million in 2012.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1tag:blogger.com,1999:blog-6529035149852332300.post-16200685578122184902013-05-27T21:29:00.001-07:002013-05-27T21:29:46.177-07:00"Biological Tools from Hot Springs" Tom Schoenfeld of Lucingen September 27, 2012<table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjugrhPBxzMKEknne41zCsbAw8X_XUYFy1dnPB3BTzgCAOEvhEWd1e7cGoEmUfZxCpHG60BUggy4ktNvtDvRievgPIHvdFWoU-QRZDOe2X-LzRDNu1I2DAsotDKt6J3rUkI7JQZhUHXBP0/s1600/Schoenfeld.jpg" imageanchor="1" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjugrhPBxzMKEknne41zCsbAw8X_XUYFy1dnPB3BTzgCAOEvhEWd1e7cGoEmUfZxCpHG60BUggy4ktNvtDvRievgPIHvdFWoU-QRZDOe2X-LzRDNu1I2DAsotDKt6J3rUkI7JQZhUHXBP0/s1600/Schoenfeld.jpg" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">Tom Schoenfeld</td></tr>
</tbody></table>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Tom
Schoenfeld of Lucingen, a company that helps researchers with DNA cloning &
sequencing, will speak on "Biological Tools from Hot Springs"<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Thursday:
September 27th 5:30 pm<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Place:
McCormick & Schmicks<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Cost:
$20. RSVP here. UNLV Students & Researchers - no cost (please RSVP)<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Lucigen
makes novel enzymes such as thermostable, bacteriophage DNA polymerase &
other enzymes used for research, diagnostics, drug discovery and for producing
bioethanol.<o:p></o:p></span></div>
<div class="MsoNoSpacing">
<br /></div>
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Tom
Schoenfeld, VP of the biotech, Lucigen, is a bio-prospector of hot springs.
Working with UNLV Associate Professor & microbial ecologist, Biran Hedlund,
Schoenfeld hunts hot springs for "extremophiles" - bacteria, archae
& viruses that live in extreme conditions and contain enzymes with special
properties. The enzymes have potential applications with making biofuels, DNA,
medical and forensic diagnostics.<o:p></o:p></span></div>
<br />
<div class="MsoNoSpacing">
<span style="font-family: "Arial","sans-serif"; font-size: 14.0pt;">Nevada
has a high number of hot springs and could be sitting a gold mine of new
enzymes.<o:p></o:p></span></div>
John Laubhttp://www.blogger.com/profile/16472674463210006526noreply@blogger.com1